semaglutide and vision loss Ozempic, Wegovy linked to potential Eye Condition a 'Very Rare'

4 Frias JP, et al

LiuHLiMDengYHouYHouLZhangXet al

Geng, L

Lyophilised peptides are stable, but they are not invulnerable and Thailands climate compounds the risk profile of any package that spends weeks in transit through warehouses with inconsistent temperature control

Figure 2: Novel Incretin Mimetic Assets for T2DM and Obesity in Phase 2/3 of Development Remaining Unmet Needs Remaining Unmet Needs Though the value proposition of on-market GLP-1 and dual-agonists is strong, several key unmet needs still exist for incretin mimetics across diabetes and obesity, namely: (1) improved efficacy, (2) better tolerability, (3) more convenient options / alternative ROAs, and (4) improved access and affordability

An impeccable peptide can be rendered useless by improper storage